Peripheral Protein Quality Control as a Novel Drug Target for CFTR Stabilizer
Conformationally defective cystic fibrosis transmembrane conductance regulator (CFTR) including rescued ΔF508-CFTR is rapidly eliminated from the plasma membrane (PM) even in the presence of a CFTR corrector and potentiator, limiting the therapeutic effort of the combination therapy. CFTR eliminatio...
Saved in:
Main Authors: | Ryosuke Fukuda (Author), Tsukasa Okiyoneda (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2018-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Ubiquitylation as a Novel Pharmaceutical Target for Cystic Fibrosis
by: Ryosuke Fukuda, et al.
Published: (2020) -
Ligand-based virtual-screening identified a novel CFTR ligand which improves the defective cell surface expression of misfolded ABC transporters
by: Shogo Taniguchi, et al.
Published: (2024) -
Network Biology Identifies Novel Regulators of CFTR Trafficking and Membrane Stability
by: Cláudia Almeida Loureiro, et al.
Published: (2019) -
Identification and Characterization of Novel CFTR Potentiators
by: Maarten Gees, et al.
Published: (2018) -
CFTR Modulator Therapy for Rare CFTR Mutants
by: Marco Mergiotti, et al.
Published: (2022)